Aldeyra The ( ALDX) - Key Metrics
ALDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.09 | -$160.80 | -$161.18 |
| 2026Q1 | $0 | -$0.06 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q3 | $0 | -$0.13 | -$0.12 | -$0.12 |
| 2025Q2 | $0 | -$0.16 | -$0.14 | -$0.14 |
ALDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.92 |
| 2026Q1 | 0% | -7.39 |
| 2025Q4 | 0% | -11.77 |
| 2025Q3 | 0% | -10.04 |
| 2025Q2 | 0% | -5.98 |
ALDX
Price: $0.96
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 79624
Ebitda: -4.9 millionMarket Capitalization: 55.2 million